, , , , , , , , , , , ,

May2014NewsFebruary’s roundup of articles features stories on India’s drug standards, CRISPR gene editing, new drugs for pain management, depression, and overdosing, Obama’s Precision Medicine Initiative, and a new, major study on the link between Zika virus and birth defects.

Have a perspective on one of these stories? Submit your post to the AAPS Blog!

  1. Obama Is Using the Bully Pulpit to Set Patient Data Free,” by Matthew Herper, Forbes, February 25, 2016
  2. Whoops! 12 Tales of Accidental Brilliance In Science,” by Adam Cole, NPR, February 24, 2016
  3. CDC, Brazil Start Big Study to Test Zika Link to Birth Defects,” by Julie Steenhuysen, Scientific American, February 22, 2016
  4. The Ibuprofen Inventor,” by Julia Robinson, The Pharmaceutical Journal, February 22, 2016
  5. The Effects of the Trans-Pacific Partnership on Pharmaceutical Innovation,” Elsevier, January 22, 2016
  6. One In Every Seven Indian Drugs Is Below Standard. Is Health Minister Listening?Indiatimes, February 18, 2016
  7. Walgreens to Sell Naloxone, Heroin, and Prescription Pain Med Overdose Antidote, over the Counter,” by Susan Scutti, Medical Daily, February 10, 2016
  8. CRISPR, but No Clearer about the Human Embryo,” by Javier Cuadros, Mercatornet February 9, 2016
  9. This New Drug is as Strong as Morphine, but without the Side Effects,” by Peter Dockrill, Science Alert, February 1, 2016
  10. Onetime Party Drug Hailed as Miracle for Treating Severe Depression,” by Sara Solovitch, The Washington Post, February 1, 2016
  11. How to Give a C-section Baby the Potential Benefits of Vaginal Birth,” by Jennifer Couzin-Frankel, Science, February 1, 2016